Odette Cancer Research
Cancer is the leading cause of premature death in Canada. This year in Ontario, 50,000 people will be diagnosed with cancer and almost 25,000 will die. The Odette cancer research program at Sunnybrook Research Institute (SRI) seeks to understand the basis of cancer and to improve prevention and treatment.
Our areas of focus range from the basic genetics, biochemistry and biology of cancer, through new experimental treatments to social factors and quality of life of patients living with cancer.
Researchers in the program include:
- medical and radiation oncologists
- surgical oncologists
- molecular biologists
- imaging scientists
- many other health care specialists
Clinicians and scientists examine a variety of cancers, with strong emphasis on three strategic foci: prostate, breast and colorectal cancer. Our research is geared toward early detection and the development of new treatments.
Sunnybrook has been remarkably successful in translation research, defined as research that has potential for direct clinical impact, whether by bringing basic laboratory science into the clinic, or by moving the findings of clinical trials or epidemiological studies into the realm of health policy.